Sandesh Seth
Fortuna: 206 619 $ al 30/09/2026
Fortuna: 206 619 $ al 30/09/2026
Mr. Sandesh Seth is a Chairman & Chief Executive Officer at Actinium Pharmaceuticals, Inc. and a Managing Partner at Jamess Capital Group LLC.
Mr. Seth was previously employed as a Lead Director by Camp Nine, Inc., a Lead Director by Relmada Therapeutics, Inc. /Old/, a Chairman by Relmada Therapeutics, Inc., and a Head-Healthcare Investment Banking by Laidlaw & Co. (UK) Ltd. He also served on the board at Cactus Ventures, Inc. and Actinium Pharmaceuticals, Inc. /Old/.
He received his undergraduate degree from the University of Mumbai and an MBA from New York University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 02/10/2026 | 184.481 ( 0,59 % ) | 206 619 $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Director Ejecutivo | 09/06/2017 |
Jamess Capital Group LLC | Corporate Officer/Principal | - |
| Empresas | Cargo | Fin |
|---|---|---|
| RELMADA THERAPEUTICS, INC. | Presidente | 06/06/2017 |
Laidlaw & Co. (UK) Ltd.
Laidlaw & Co. (UK) Ltd. Investment Banks/BrokersFinance Provides investment advice | Corporate Officer/Principal | 01/07/2015 |
Actinium Pharmaceuticals, Inc. /Old/
Actinium Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Develops and commercializes alpha particle immunotherapeutics | Director/Miembro de la Junta | 18/04/2013 |
Cactus Ventures, Inc.
Cactus Ventures, Inc. Financial ConglomeratesFinance Operates as a blank check company | Director/Miembro de la Junta | 18/04/2013 |
Camp Nine, Inc.
Camp Nine, Inc. Pharmaceuticals: GenericHealth Technology Operates as a clinical stage biopharmaceutical company | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
Actinium Pharmaceuticals, Inc. /Old/
Actinium Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Develops and commercializes alpha particle immunotherapeutics | Commercial Services |
Cactus Ventures, Inc.
Cactus Ventures, Inc. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Camp Nine, Inc.
Camp Nine, Inc. Pharmaceuticals: GenericHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
New York University
New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Mumbai
University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Laidlaw & Co. (UK) Ltd.
Laidlaw & Co. (UK) Ltd. Investment Banks/BrokersFinance Provides investment advice | Finance |
Relmada Therapeutics, Inc. /Old/
Relmada Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs for the treatment of acute and chronic pains | Health Technology |
Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
Jamess Capital Group LLC | |
Relmada Therapeutics, Inc.
Relmada Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products for the treatment of depression and other central nervous system diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.